Correction: Pharmacological Reports 10.1007/s43440-022-00408-6
In the sections of "Abstract", "Patients and Methods” and Table 1, 31 April should be corrected to 30 April.
The original article has been corrected.
. 2022 Oct 3;74(6):1328. doi: 10.1007/s43440-022-00419-3
Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
Robert Flisiak
1,✉,#, Dorota Zarębska-Michaluk
2,3,#, Magdalena Rogalska
1, Justyna Anna Kryńska
1, Justyna Kowalska
4, Ewa Dutkiewicz
5,6, Krystyna Dobrowolska
2, Jerzy Jaroszewicz
7, Anna Moniuszko-Malinowska
8, Marta Rorat
9, Regina Podlasin
10, Olga Tronina
11, Piotr Rzymski
12
Robert Flisiak
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540, ul. Żurawia 14, Białystok, Poland
Find articles by Robert Flisiak
Dorota Zarębska-Michaluk
2Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
3Provincial Hospital, Kielce, Poland
Find articles by Dorota Zarębska-Michaluk
Magdalena Rogalska
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540, ul. Żurawia 14, Białystok, Poland
Find articles by Magdalena Rogalska
Justyna Anna Kryńska
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540, ul. Żurawia 14, Białystok, Poland
Find articles by Justyna Anna Kryńska
Justyna Kowalska
4Department of Adults’ Infectious Diseases, Medical University of Warsaw, Warsaw, Poland
Find articles by Justyna Kowalska
Ewa Dutkiewicz
5ZOZ, Busko Zdroj, Poland
6Jan Kochanowski University, Collegium Medicum, Kielce, Poland
Find articles by Ewa Dutkiewicz
Krystyna Dobrowolska
2Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
Find articles by Krystyna Dobrowolska
Jerzy Jaroszewicz
7Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland
Find articles by Jerzy Jaroszewicz
Anna Moniuszko-Malinowska
8Department of Infectious Diseases and Neuroinfections, Medical University of Białystok, Białystok, Poland
Find articles by Anna Moniuszko-Malinowska
Marta Rorat
9Department of Forensic Medicine, Wrocław Medical University, Wrocław, Poland
Find articles by Marta Rorat
Regina Podlasin
10IV-th Department, Hospital for Infectious Diseases, Warsaw, Poland
Find articles by Regina Podlasin
Olga Tronina
11Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
Find articles by Olga Tronina
Piotr Rzymski
12Department of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland
Find articles by Piotr Rzymski
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540, ul. Żurawia 14, Białystok, Poland
2Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
3Provincial Hospital, Kielce, Poland
4Department of Adults’ Infectious Diseases, Medical University of Warsaw, Warsaw, Poland
5ZOZ, Busko Zdroj, Poland
6Jan Kochanowski University, Collegium Medicum, Kielce, Poland
7Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland
8Department of Infectious Diseases and Neuroinfections, Medical University of Białystok, Białystok, Poland
9Department of Forensic Medicine, Wrocław Medical University, Wrocław, Poland
10IV-th Department, Hospital for Infectious Diseases, Warsaw, Poland
11Department of Transplantation Medicine, Nephrology, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
12Department of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland
✉
Corresponding author.
#
Contributed equally.
Issue date 2022.
© The Author(s) 2022
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC9527374 PMID: 36190677
This corrects the article "Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance" on page 1279.